• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

American-born Asian women more likely to have endometrial cancer

byMarisa LiuandLeah Hawkins Bressler, MD, MPH
July 20, 2014
in Chronic Disease, Obstetrics, Oncology, Public Health
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Compared to Asian immigrants, American-born Asian women are more likely to develop Type I (estrogen-dependent) endometrial adenocarcinoma. 

2. Among Asian women, being born in America is an independent risk factor for development of Type I endometrial cancer. 

Evidence Rating Level: 2 (Good) 

Study Rundown: Endometrial cancer is the most common gynecologic malignancy, with an incidence of nearly 50,000 new cases diagnosed each year. Endometrial cancer comes in two types. Type I is driven by excess estrogen production, usually endogenous (obesity-driven peripheral conversion of estrogen) such that rates are highest in industrialized countries. Type II is estrogen-independent, more aggressive and likely driven by genetics. In determining the extent to which nature vs. nurture determines cancer susceptibility, previous investigations have examined rates of various cancers among immigrants compared to American-born members of the same ethnicity. Prior research demonstrates an increased incidence of breast and gynecologic malignancies among American-born compared to immigrant Asian women. Yet, little is known about differences in risk of Type I and Type II endometrial cancers in these groups. In this study, researchers compared the proportion of Type I to Type II endometrial cancers among American-born Asian women and immigrant women. Findings demonstrate that Type I endometrial cancer was more common among American-born Asian women and also that the incidence of Type I disease increased over time, suggesting that the cancer-promoting risk factors related to being American-born are becoming more impactful over time.

Limitations include retrospective design, which creates opportunity for bias. Additionally, this study did not examine other common risk factors for endometrial cancer (nulliparity, anovulation, hypertension) and notably did not evaluate BMI. However, the relationships identified herein have strong foundation of biologic plausibility. Strengths include large sample size and nationally representative sample, increasing applicability of results. Future investigations might employ a prospective design and collect data on risk factors (BMI, ovulatory dysfunction, family cancer history) to better address this research question.

Click to read study in AJOG

RELATED REPORTS

Lenvatinib plus pembrolizumab not associated with improved survival compared to standard therapy for recurrent endometrial cancer

GSK’s Jemperli in combination with chemotherapy shows improved overall survival in patients with endometrial cancer.

#VisualAbstract: Atezolizumab and Chemotherapy Improve Outcomes in Advanced or Recurrent Endometrial Cancer

Relevant Reading: Improved survival of Asians with corpus cancer compared with whites: an analysis of underlying factors

In-Depth [cross-sectional study]: Used data from the Surveillance, Epidemiology and End Results (SEER) database to examine information of 4,834 women from Utah, Hawaii, Iowa, New Mexico, Connecticut, Alaska, and the cities Detroit, San Francisco/Oakland, Seattle, Atlanta, San Jose/Monterey and Los Angeles. Asian women included those who self-identify as Chinese, Filipino, Japanese, Korean, South-East Asian and Indian descent. Type I cancers were defined as grade 1 or 2 endometrioid carcinomas. Type II cancers were defined as grade 3 endometrioid, clear cell or serous.

Among Asian women, being born in America is an independent risk factor for development of Type I endometrial cancer (HR: 1.95, CI:1.73-2.20; p<0.01). Over the study period (2001-2009), the incidence of Type I endometrial adenocarcinoma in American-born Asian women increased from 61% to 68% (p<0.01). The 5-year disease specific survival rates of Type I endometrioid carcinoma were the same for both groups (92%).

Image: CC/Wiki/KGH

More from this author: Malignancy incidence with laparoscopic ovarian cystectomy

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.  

Tags: endometrial cancer
Previous Post

Dermatologic screening demands may exceed recommended follow-up frequencies

Next Post

Peer-mentored therapy reduces distress in mothers of children with disabilities

RelatedReports

Quick Take: The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): a pragmatic, double-blind, placebo-controlled randomized trial
Obstetrics

Lenvatinib plus pembrolizumab not associated with improved survival compared to standard therapy for recurrent endometrial cancer

March 20, 2025
American-born Asian women more likely to have endometrial cancer
Pharma

GSK’s Jemperli in combination with chemotherapy shows improved overall survival in patients with endometrial cancer.

August 15, 2024
#VisualAbstract: Atezolizumab and Chemotherapy Improve Outcomes in Advanced or Recurrent Endometrial Cancer
StudyGraphics

#VisualAbstract: Atezolizumab and Chemotherapy Improve Outcomes in Advanced or Recurrent Endometrial Cancer

August 14, 2024
American-born Asian women more likely to have endometrial cancer
Oncology

The addition of cisplatin to standard-of-care radiation therapy does not appear to improve progression-free survival for patients with localized recurrent endometrial cancer.

April 29, 2024
Next Post
Severe maternal childhood abuse associated with autism in offspring

Peer-mentored therapy reduces distress in mothers of children with disabilities

3D mammography (tomosynthesis) enhances accuracy of breast cancer screening

Minimal survival benefit from contralateral prophylactic mastectomy

Gestational weight loss may improve outcomes for obese women

Weight loss intervention concurrently targeting parent and child benefits both parties

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Regional anesthesia and functional outcomes after anterior cruciate ligament reconstruction surgery in adolescent patients: Society of Pediatric Anesthesia Improvement Network (SPAIN)
  • Subcutaneous Dexmedetomidine for Refractory Symptoms in a Hospice Inpatient Unit
  • Risk of infection and wound dehiscence after use of prophylactic antibiotics in episiotomy or second degree tear (REPAIR study): single centre, double blind, placebo-controlled randomised trial
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.